Compare Keysight Technologies Inc (KEYS) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Keysight Technologies Inc vs Revvity Inc — how do they compare? Keysight Technologies Inc trades at $354.79 (market cap $58.74B), while Revvity Inc trades at $116.28 (market cap $12.91B). The key difference: Keysight Technologies Inc is far larger — about 4.5× Revvity Inc's market cap, and Revvity Inc pays a 0.24% dividend while Keysight Technologies Inc pays none. Which is the better fit depends on your goals.
| KEYS | RVTY | |
|---|---|---|
Market Cap | $58.74B | $12.91B |
Sector | Technology | Technology |
52-Week High | $373.34 | $117.75 |
52-Week Low | $158.51 | $82.26 |
Enterprise Value | $59.08B | $15.23B |
Dividend Yield | — | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Keysight Technologies (KEYS) trades at $353.23, up 5.31% over the past day and showing strong momentum. The stock is in a bullish technical trend, with recent earnings consistently beating estimates. Revenue for 2025 was $5.38 billion, with a net income margin of 17.31%, and the company has announced strategic collaborations and product launches in 2026, including advancements in 5G and photonics design.
The outlook for KEYS is positive, supported by robust earnings performance and analyst optimism, with an average price target of $396.56. Key risks include high valuation multiples and significant capital expenditure trends. Upside potential hinges on continued execution and market adoption of new technologies.
RVTY trades at $116.10, up 0.07% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $1.41, surpassing the $1.21 estimate, and raised its full-year outlook due to robust diagnostics demand. Revenue remains steady around $2.9 billion, with a net income margin of 8.16%. Analyst consensus is a Buy with a $120.50 price target, and recent news highlights product launches like the SuperFlex prenatal system and high-throughput TB testing platform.
The outlook for RVTY is positive, supported by earnings momentum and strategic innovations, but investors face risks from high valuation multiples and competitive pressures in the healthcare sector. The stock's proximity to its consensus target suggests limited near-term upside, requiring careful monitoring of execution against raised guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
